Global Antibacterial (Drug) Resistance Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Antibacterial (Drug) Resistance Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Antibacterial (Drug) Resistance by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Antibacterial (Drug) Resistance by Country/Region, 2017, 2022 & 2028

2.2 Antibacterial (Drug) Resistance Segment by Type

2.2.1 Telavancin (Vibativ)

2.2.2 Ceftaroline Fosamil (Teflaro/ Zinforo)

2.2.3 Fidaxomicin (Dificid / Dificlir)

2.2.4 Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio)

2.2.5 Dalbavancin (Dalvance/ Xydalba)

2.2.6 Tedizolid Phosphate (Sivextro)

2.2.7 Oritavancin (Orbactiv/ Nuvocid)

2.2.8 Ceftolozane-Tazobactam (Zerbaxa)

2.2.9 Ceftazidime-Avibactam (Avycaz/ Zavicefta)

2.2.10 PHASE III DRUGS

2.3 Antibacterial (Drug) Resistance Sales by Type

2.3.1 Global Antibacterial (Drug) Resistance Sales Market Share by Type (2017-2022)

2.3.2 Global Antibacterial (Drug) Resistance Revenue and Market Share by Type (2017-2022)

2.3.3 Global Antibacterial (Drug) Resistance Sale Price by Type (2017-2022)

2.4 Antibacterial (Drug) Resistance Segment by Indication

2.4.1 Complicated Urinary Tract Infection (CUTI)

2.4.2 Complicated Intra-Abdominal Infections (CIAI)

2.4.3 Blood Stream Infections (BSI)

2.4.4 Clostridium Difficile Infections (CDI)

2.4.5 Acute Bacterial Skin And Skin Structure Infections (ABSSSI)

2.4.6 Hospital Acquired Bacterial Pneumonia/Ventilator (HABP/VABP)

2.4.7 Community Acquired Bacterial Pneumonia (CABP)

2.5 Antibacterial (Drug) Resistance Sales by Indication

2.5.1 Global Antibacterial (Drug) Resistance Sale Market Share by Indication (2017-2022)

2.5.2 Global Antibacterial (Drug) Resistance Revenue and Market Share by Indication (2017-2022)

2.5.3 Global Antibacterial (Drug) Resistance Sale Price by Indication (2017-2022)

3 Global Antibacterial (Drug) Resistance by Company

3.1 Global Antibacterial (Drug) Resistance Breakdown Data by Company

3.1.1 Global Antibacterial (Drug) Resistance Annual Sales by Company (2020-2022)

3.1.2 Global Antibacterial (Drug) Resistance Sales Market Share by Company (2020-2022)

3.2 Global Antibacterial (Drug) Resistance Annual Revenue by Company (2020-2022)

3.2.1 Global Antibacterial (Drug) Resistance Revenue by Company (2020-2022)

3.2.2 Global Antibacterial (Drug) Resistance Revenue Market Share by Company (2020-2022)

3.3 Global Antibacterial (Drug) Resistance Sale Price by Company

3.4 Key Manufacturers Antibacterial (Drug) Resistance Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Antibacterial (Drug) Resistance Product Location Distribution

3.4.2 Players Antibacterial (Drug) Resistance Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Antibacterial (Drug) Resistance by Geographic Region

4.1 World Historic Antibacterial (Drug) Resistance Market Size by Geographic Region (2017-2022)

4.1.1 Global Antibacterial (Drug) Resistance Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Antibacterial (Drug) Resistance Annual Revenue by Geographic Region

4.2 World Historic Antibacterial (Drug) Resistance Market Size by Country/Region (2017-2022)

4.2.1 Global Antibacterial (Drug) Resistance Annual Sales by Country/Region (2017-2022)

4.2.2 Global Antibacterial (Drug) Resistance Annual Revenue by Country/Region

4.3 Americas Antibacterial (Drug) Resistance Sales Growth

4.4 APAC Antibacterial (Drug) Resistance Sales Growth

4.5 Europe Antibacterial (Drug) Resistance Sales Growth

4.6 Middle East & Africa Antibacterial (Drug) Resistance Sales Growth

5 Americas

5.1 Americas Antibacterial (Drug) Resistance Sales by Country

5.1.1 Americas Antibacterial (Drug) Resistance Sales by Country (2017-2022)

5.1.2 Americas Antibacterial (Drug) Resistance Revenue by Country (2017-2022)

5.2 Americas Antibacterial (Drug) Resistance Sales by Type

5.3 Americas Antibacterial (Drug) Resistance Sales by Indication

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Antibacterial (Drug) Resistance Sales by Region

6.1.1 APAC Antibacterial (Drug) Resistance Sales by Region (2017-2022)

6.1.2 APAC Antibacterial (Drug) Resistance Revenue by Region (2017-2022)

6.2 APAC Antibacterial (Drug) Resistance Sales by Type

6.3 APAC Antibacterial (Drug) Resistance Sales by Indication

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Antibacterial (Drug) Resistance by Country

7.1.1 Europe Antibacterial (Drug) Resistance Sales by Country (2017-2022)

7.1.2 Europe Antibacterial (Drug) Resistance Revenue by Country (2017-2022)

7.2 Europe Antibacterial (Drug) Resistance Sales by Type

7.3 Europe Antibacterial (Drug) Resistance Sales by Indication

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Antibacterial (Drug) Resistance by Country

8.1.1 Middle East & Africa Antibacterial (Drug) Resistance Sales by Country (2017-2022)

8.1.2 Middle East & Africa Antibacterial (Drug) Resistance Revenue by Country (2017-2022)

8.2 Middle East & Africa Antibacterial (Drug) Resistance Sales by Type

8.3 Middle East & Africa Antibacterial (Drug) Resistance Sales by Indication

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Antibacterial (Drug) Resistance

10.3 Manufacturing Process Analysis of Antibacterial (Drug) Resistance

10.4 Industry Chain Structure of Antibacterial (Drug) Resistance

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Antibacterial (Drug) Resistance Distributors

11.3 Antibacterial (Drug) Resistance Customer

12 World Forecast Review for Antibacterial (Drug) Resistance by Geographic Region

12.1 Global Antibacterial (Drug) Resistance Market Size Forecast by Region

12.1.1 Global Antibacterial (Drug) Resistance Forecast by Region (2023-2028)

12.1.2 Global Antibacterial (Drug) Resistance Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Antibacterial (Drug) Resistance Forecast by Type

12.7 Global Antibacterial (Drug) Resistance Forecast by Indication

13 Key Players Analysis

13.1 Melinta Therapeutics

13.1.1 Melinta Therapeutics Company Information

13.1.2 Melinta Therapeutics Antibacterial (Drug) Resistance Product Offered

13.1.3 Melinta Therapeutics Antibacterial (Drug) Resistance Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Melinta Therapeutics Main Business Overview

13.1.5 Melinta Therapeutics Latest Developments

13.2 Allergan

13.2.1 Allergan Company Information

13.2.2 Allergan Antibacterial (Drug) Resistance Product Offered

13.2.3 Allergan Antibacterial (Drug) Resistance Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Allergan Main Business Overview

13.2.5 Allergan Latest Developments

13.3 Merck

13.3.1 Merck Company Information

13.3.2 Merck Antibacterial (Drug) Resistance Product Offered

13.3.3 Merck Antibacterial (Drug) Resistance Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Merck Main Business Overview

13.3.5 Merck Latest Developments

13.4 Abbott Laboratories

13.4.1 Abbott Laboratories Company Information

13.4.2 Abbott Laboratories Antibacterial (Drug) Resistance Product Offered

13.4.3 Abbott Laboratories Antibacterial (Drug) Resistance Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Abbott Laboratories Main Business Overview

13.4.5 Abbott Laboratories Latest Developments

13.5 Pfizer

13.5.1 Pfizer Company Information

13.5.2 Pfizer Antibacterial (Drug) Resistance Product Offered

13.5.3 Pfizer Antibacterial (Drug) Resistance Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Pfizer Main Business Overview

13.5.5 Pfizer Latest Developments

13.6 GSK

13.6.1 GSK Company Information

13.6.2 GSK Antibacterial (Drug) Resistance Product Offered

13.6.3 GSK Antibacterial (Drug) Resistance Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 GSK Main Business Overview

13.6.5 GSK Latest Developments

13.7 PENDOPHARM

13.7.1 PENDOPHARM Company Information

13.7.2 PENDOPHARM Antibacterial (Drug) Resistance Product Offered

13.7.3 PENDOPHARM Antibacterial (Drug) Resistance Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 PENDOPHARM Main Business Overview

13.7.5 PENDOPHARM Latest Developments

13.8 Absynth Biologics

13.8.1 Absynth Biologics Company Information

13.8.2 Absynth Biologics Antibacterial (Drug) Resistance Product Offered

13.8.3 Absynth Biologics Antibacterial (Drug) Resistance Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Absynth Biologics Main Business Overview

13.8.5 Absynth Biologics Latest Developments

13.9 Achaogen

13.9.1 Achaogen Company Information

13.9.2 Achaogen Antibacterial (Drug) Resistance Product Offered

13.9.3 Achaogen Antibacterial (Drug) Resistance Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Achaogen Main Business Overview

13.9.5 Achaogen Latest Developments

13.10 Acino Holdings

13.10.1 Acino Holdings Company Information

13.10.2 Acino Holdings Antibacterial (Drug) Resistance Product Offered

13.10.3 Acino Holdings Antibacterial (Drug) Resistance Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Acino Holdings Main Business Overview

13.10.5 Acino Holdings Latest Developments

13.11 Aventis Pharma

13.11.1 Aventis Pharma Company Information

13.11.2 Aventis Pharma Antibacterial (Drug) Resistance Product Offered

13.11.3 Aventis Pharma Antibacterial (Drug) Resistance Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Aventis Pharma Main Business Overview

13.11.5 Aventis Pharma Latest Developments

13.12 Austell Laboratories

13.12.1 Austell Laboratories Company Information

13.12.2 Austell Laboratories Antibacterial (Drug) Resistance Product Offered

13.12.3 Austell Laboratories Antibacterial (Drug) Resistance Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Austell Laboratories Main Business Overview

13.12.5 Austell Laboratories Latest Developments

13.13 Assembly Biosciences

13.13.1 Assembly Biosciences Company Information

13.13.2 Assembly Biosciences Antibacterial (Drug) Resistance Product Offered

13.13.3 Assembly Biosciences Antibacterial (Drug) Resistance Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Assembly Biosciences Main Business Overview

13.13.5 Assembly Biosciences Latest Developments

13.14 Arpida

13.14.1 Arpida Company Information

13.14.2 Arpida Antibacterial (Drug) Resistance Product Offered

13.14.3 Arpida Antibacterial (Drug) Resistance Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Arpida Main Business Overview

13.14.5 Arpida Latest Developments

13.15 Demuris

13.15.1 Demuris Company Information

13.15.2 Demuris Antibacterial (Drug) Resistance Product Offered

13.15.3 Demuris Antibacterial (Drug) Resistance Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Demuris Main Business Overview

13.15.5 Demuris Latest Developments

13.16 Evolva Holding

13.16.1 Evolva Holding Company Information

13.16.2 Evolva Holding Antibacterial (Drug) Resistance Product Offered

13.16.3 Evolva Holding Antibacterial (Drug) Resistance Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Evolva Holding Main Business Overview

13.16.5 Evolva Holding Latest Developments

13.17 ContraFect

13.17.1 ContraFect Company Information

13.17.2 ContraFect Antibacterial (Drug) Resistance Product Offered

13.17.3 ContraFect Antibacterial (Drug) Resistance Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 ContraFect Main Business Overview

13.17.5 ContraFect Latest Developments

13.18 Cerexa

13.18.1 Cerexa Company Information

13.18.2 Cerexa Antibacterial (Drug) Resistance Product Offered

13.18.3 Cerexa Antibacterial (Drug) Resistance Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Cerexa Main Business Overview

13.18.5 Cerexa Latest Developments

13.19 InterMune

13.19.1 InterMune Company Information

13.19.2 InterMune Antibacterial (Drug) Resistance Product Offered

13.19.3 InterMune Antibacterial (Drug) Resistance Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 InterMune Main Business Overview

13.19.5 InterMune Latest Developments

13.20 Isis Pharmaceuticals

13.20.1 Isis Pharmaceuticals Company Information

13.20.2 Isis Pharmaceuticals Antibacterial (Drug) Resistance Product Offered

13.20.3 Isis Pharmaceuticals Antibacterial (Drug) Resistance Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Isis Pharmaceuticals Main Business Overview

13.20.5 Isis Pharmaceuticals Latest Developments

13.21 Lyndra

13.21.1 Lyndra Company Information

13.21.2 Lyndra Antibacterial (Drug) Resistance Product Offered

13.21.3 Lyndra Antibacterial (Drug) Resistance Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 Lyndra Main Business Overview

13.21.5 Lyndra Latest Developments

13.22 Microbecide

13.22.1 Microbecide Company Information

13.22.2 Microbecide Antibacterial (Drug) Resistance Product Offered

13.22.3 Microbecide Antibacterial (Drug) Resistance Sales, Revenue, Price and Gross Margin (2020-2022)

13.22.4 Microbecide Main Business Overview

13.22.5 Microbecide Latest Developments

13.23 Morphochem

13.23.1 Morphochem Company Information

13.23.2 Morphochem Antibacterial (Drug) Resistance Product Offered

13.23.3 Morphochem Antibacterial (Drug) Resistance Sales, Revenue, Price and Gross Margin (2020-2022)

13.23.4 Morphochem Main Business Overview

13.23.5 Morphochem Latest Developments

13.24 Nabriva Therapeutics

13.24.1 Nabriva Therapeutics Company Information

13.24.2 Nabriva Therapeutics Antibacterial (Drug) Resistance Product Offered

13.24.3 Nabriva Therapeutics Antibacterial (Drug) Resistance Sales, Revenue, Price and Gross Margin (2020-2022)

13.24.4 Nabriva Therapeutics Main Business Overview

13.24.5 Nabriva Therapeutics Latest Developments

13.25 NanoSafe Coatings

13.25.1 NanoSafe Coatings Company Information

13.25.2 NanoSafe Coatings Antibacterial (Drug) Resistance Product Offered

13.25.3 NanoSafe Coatings Antibacterial (Drug) Resistance Sales, Revenue, Price and Gross Margin (2020-2022)

13.25.4 NanoSafe Coatings Main Business Overview

13.25.5 NanoSafe Coatings Latest Developments

13.26 Novexel

13.26.1 Novexel Company Information

13.26.2 Novexel Antibacterial (Drug) Resistance Product Offered

13.26.3 Novexel Antibacterial (Drug) Resistance Sales, Revenue, Price and Gross Margin (2020-2022)

13.26.4 Novexel Main Business Overview

13.26.5 Novexel Latest Developments

13.27 Osel

13.27.1 Osel Company Information

13.27.2 Osel Antibacterial (Drug) Resistance Product Offered

13.27.3 Osel Antibacterial (Drug) Resistance Sales, Revenue, Price and Gross Margin (2020-2022)

13.27.4 Osel Main Business Overview

13.27.5 Osel Latest Developments

13.28 VenatoRx Pharmaceuticals

13.28.1 VenatoRx Pharmaceuticals Company Information

13.28.2 VenatoRx Pharmaceuticals Antibacterial (Drug) Resistance Product Offered

13.28.3 VenatoRx Pharmaceuticals Antibacterial (Drug) Resistance Sales, Revenue, Price and Gross Margin (2020-2022)

13.28.4 VenatoRx Pharmaceuticals Main Business Overview

13.28.5 VenatoRx Pharmaceuticals Latest Developments

13.29 AAIPharma Services

13.29.1 AAIPharma Services Company Information

13.29.2 AAIPharma Services Antibacterial (Drug) Resistance Product Offered

13.29.3 AAIPharma Services Antibacterial (Drug) Resistance Sales, Revenue, Price and Gross Margin (2020-2022)

13.29.4 AAIPharma Services Main Business Overview

13.29.5 AAIPharma Services Latest Developments

13.30 ANTABIO

13.30.1 ANTABIO Company Information

13.30.2 ANTABIO Antibacterial (Drug) Resistance Product Offered

13.30.3 ANTABIO Antibacterial (Drug) Resistance Sales, Revenue, Price and Gross Margin (2020-2022)

13.30.4 ANTABIO Main Business Overview

13.30.5 ANTABIO Latest Developments

14 Research Findings and Conclusion

Table 1. Antibacterial (Drug) Resistance Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Antibacterial (Drug) Resistance Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Telavancin (Vibativ)

Table 4. Major Players of Ceftaroline Fosamil (Teflaro/ Zinforo)

Table 5. Major Players of Fidaxomicin (Dificid / Dificlir)

Table 6. Major Players of Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio)

Table 7. Major Players of Dalbavancin (Dalvance/ Xydalba)

Table 8. Major Players of Tedizolid Phosphate (Sivextro)

Table 9. Major Players of Oritavancin (Orbactiv/ Nuvocid)

Table 10. Major Players of Ceftolozane-Tazobactam (Zerbaxa)

Table 11. Major Players of Ceftazidime-Avibactam (Avycaz/ Zavicefta)

Table 12. Major Players of PHASE III DRUGS

Table 13. Global Antibacterial (Drug) Resistance Sales by Type (2017-2022) & (K Units)

Table 14. Global Antibacterial (Drug) Resistance Sales Market Share by Type (2017-2022)

Table 15. Global Antibacterial (Drug) Resistance Revenue by Type (2017-2022) & ($ million)

Table 16. Global Antibacterial (Drug) Resistance Revenue Market Share by Type (2017-2022)

Table 17. Global Antibacterial (Drug) Resistance Sale Price by Type (2017-2022) & (USD/Unit)

Table 18. Global Antibacterial (Drug) Resistance Sales by Indication (2017-2022) & (K Units)

Table 19. Global Antibacterial (Drug) Resistance Sales Market Share by Indication (2017-2022)

Table 20. Global Antibacterial (Drug) Resistance Revenue by Indication (2017-2022)

Table 21. Global Antibacterial (Drug) Resistance Revenue Market Share by Indication (2017-2022)

Table 22. Global Antibacterial (Drug) Resistance Sale Price by Indication (2017-2022) & (USD/Unit)

Table 23. Global Antibacterial (Drug) Resistance Sales by Company (2020-2022) & (K Units)

Table 24. Global Antibacterial (Drug) Resistance Sales Market Share by Company (2020-2022)

Table 25. Global Antibacterial (Drug) Resistance Revenue by Company (2020-2022) ($ Millions)

Table 26. Global Antibacterial (Drug) Resistance Revenue Market Share by Company (2020-2022)

Table 27. Global Antibacterial (Drug) Resistance Sale Price by Company (2020-2022) & (USD/Unit)

Table 28. Key Manufacturers Antibacterial (Drug) Resistance Producing Area Distribution and Sales Area

Table 29. Players Antibacterial (Drug) Resistance Products Offered

Table 30. Antibacterial (Drug) Resistance Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 31. New Products and Potential Entrants

Table 32. Mergers & Acquisitions, Expansion

Table 33. Global Antibacterial (Drug) Resistance Sales by Geographic Region (2017-2022) & (K Units)

Table 34. Global Antibacterial (Drug) Resistance Sales Market Share Geographic Region (2017-2022)

Table 35. Global Antibacterial (Drug) Resistance Revenue by Geographic Region (2017-2022) & ($ millions)

Table 36. Global Antibacterial (Drug) Resistance Revenue Market Share by Geographic Region (2017-2022)

Table 37. Global Antibacterial (Drug) Resistance Sales by Country/Region (2017-2022) & (K Units)

Table 38. Global Antibacterial (Drug) Resistance Sales Market Share by Country/Region (2017-2022)

Table 39. Global Antibacterial (Drug) Resistance Revenue by Country/Region (2017-2022) & ($ millions)

Table 40. Global Antibacterial (Drug) Resistance Revenue Market Share by Country/Region (2017-2022)

Table 41. Americas Antibacterial (Drug) Resistance Sales by Country (2017-2022) & (K Units)

Table 42. Americas Antibacterial (Drug) Resistance Sales Market Share by Country (2017-2022)

Table 43. Americas Antibacterial (Drug) Resistance Revenue by Country (2017-2022) & ($ Millions)

Table 44. Americas Antibacterial (Drug) Resistance Revenue Market Share by Country (2017-2022)

Table 45. Americas Antibacterial (Drug) Resistance Sales by Type (2017-2022) & (K Units)

Table 46. Americas Antibacterial (Drug) Resistance Sales Market Share by Type (2017-2022)

Table 47. Americas Antibacterial (Drug) Resistance Sales by Indication (2017-2022) & (K Units)

Table 48. Americas Antibacterial (Drug) Resistance Sales Market Share by Indication (2017-2022)

Table 49. APAC Antibacterial (Drug) Resistance Sales by Region (2017-2022) & (K Units)

Table 50. APAC Antibacterial (Drug) Resistance Sales Market Share by Region (2017-2022)

Table 51. APAC Antibacterial (Drug) Resistance Revenue by Region (2017-2022) & ($ Millions)

Table 52. APAC Antibacterial (Drug) Resistance Revenue Market Share by Region (2017-2022)

Table 53. APAC Antibacterial (Drug) Resistance Sales by Type (2017-2022) & (K Units)

Table 54. APAC Antibacterial (Drug) Resistance Sales Market Share by Type (2017-2022)

Table 55. APAC Antibacterial (Drug) Resistance Sales by Indication (2017-2022) & (K Units)

Table 56. APAC Antibacterial (Drug) Resistance Sales Market Share by Indication (2017-2022)

Table 57. Europe Antibacterial (Drug) Resistance Sales by Country (2017-2022) & (K Units)

Table 58. Europe Antibacterial (Drug) Resistance Sales Market Share by Country (2017-2022)

Table 59. Europe Antibacterial (Drug) Resistance Revenue by Country (2017-2022) & ($ Millions)

Table 60. Europe Antibacterial (Drug) Resistance Revenue Market Share by Country (2017-2022)

Table 61. Europe Antibacterial (Drug) Resistance Sales by Type (2017-2022) & (K Units)

Table 62. Europe Antibacterial (Drug) Resistance Sales Market Share by Type (2017-2022)

Table 63. Europe Antibacterial (Drug) Resistance Sales by Indication (2017-2022) & (K Units)

Table 64. Europe Antibacterial (Drug) Resistance Sales Market Share by Indication (2017-2022)

Table 65. Middle East & Africa Antibacterial (Drug) Resistance Sales by Country (2017-2022) & (K Units)

Table 66. Middle East & Africa Antibacterial (Drug) Resistance Sales Market Share by Country (2017-2022)

Table 67. Middle East & Africa Antibacterial (Drug) Resistance Revenue by Country (2017-2022) & ($ Millions)

Table 68. Middle East & Africa Antibacterial (Drug) Resistance Revenue Market Share by Country (2017-2022)

Table 69. Middle East & Africa Antibacterial (Drug) Resistance Sales by Type (2017-2022) & (K Units)

Table 70. Middle East & Africa Antibacterial (Drug) Resistance Sales Market Share by Type (2017-2022)

Table 71. Middle East & Africa Antibacterial (Drug) Resistance Sales by Indication (2017-2022) & (K Units)

Table 72. Middle East & Africa Antibacterial (Drug) Resistance Sales Market Share by Indication (2017-2022)

Table 73. Key Market Drivers & Growth Opportunities of Antibacterial (Drug) Resistance

Table 74. Key Market Challenges & Risks of Antibacterial (Drug) Resistance

Table 75. Key Industry Trends of Antibacterial (Drug) Resistance

Table 76. Antibacterial (Drug) Resistance Raw Material

Table 77. Key Suppliers of Raw Materials

Table 78. Antibacterial (Drug) Resistance Distributors List

Table 79. Antibacterial (Drug) Resistance Customer List

Table 80. Global Antibacterial (Drug) Resistance Sales Forecast by Region (2023-2028) & (K Units)

Table 81. Global Antibacterial (Drug) Resistance Sales Market Forecast by Region

Table 82. Global Antibacterial (Drug) Resistance Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Global Antibacterial (Drug) Resistance Revenue Market Share Forecast by Region (2023-2028)

Table 84. Americas Antibacterial (Drug) Resistance Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Americas Antibacterial (Drug) Resistance Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. APAC Antibacterial (Drug) Resistance Sales Forecast by Region (2023-2028) & (K Units)

Table 87. APAC Antibacterial (Drug) Resistance Revenue Forecast by Region (2023-2028) & ($ millions)

Table 88. Europe Antibacterial (Drug) Resistance Sales Forecast by Country (2023-2028) & (K Units)

Table 89. Europe Antibacterial (Drug) Resistance Revenue Forecast by Country (2023-2028) & ($ millions)

Table 90. Middle East & Africa Antibacterial (Drug) Resistance Sales Forecast by Country (2023-2028) & (K Units)

Table 91. Middle East & Africa Antibacterial (Drug) Resistance Revenue Forecast by Country (2023-2028) & ($ millions)

Table 92. Global Antibacterial (Drug) Resistance Sales Forecast by Type (2023-2028) & (K Units)

Table 93. Global Antibacterial (Drug) Resistance Sales Market Share Forecast by Type (2023-2028)

Table 94. Global Antibacterial (Drug) Resistance Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 95. Global Antibacterial (Drug) Resistance Revenue Market Share Forecast by Type (2023-2028)

Table 96. Global Antibacterial (Drug) Resistance Sales Forecast by Indication (2023-2028) & (K Units)

Table 97. Global Antibacterial (Drug) Resistance Sales Market Share Forecast by Indication (2023-2028)

Table 98. Global Antibacterial (Drug) Resistance Revenue Forecast by Indication (2023-2028) & ($ Millions)

Table 99. Global Antibacterial (Drug) Resistance Revenue Market Share Forecast by Indication (2023-2028)

Table 100. Melinta Therapeutics Basic Information, Antibacterial (Drug) Resistance Manufacturing Base, Sales Area and Its Competitors

Table 101. Melinta Therapeutics Antibacterial (Drug) Resistance Product Offered

Table 102. Melinta Therapeutics Antibacterial (Drug) Resistance Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 103. Melinta Therapeutics Main Business

Table 104. Melinta Therapeutics Latest Developments

Table 105. Allergan Basic Information, Antibacterial (Drug) Resistance Manufacturing Base, Sales Area and Its Competitors

Table 106. Allergan Antibacterial (Drug) Resistance Product Offered

Table 107. Allergan Antibacterial (Drug) Resistance Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 108. Allergan Main Business

Table 109. Allergan Latest Developments

Table 110. Merck Basic Information, Antibacterial (Drug) Resistance Manufacturing Base, Sales Area and Its Competitors

Table 111. Merck Antibacterial (Drug) Resistance Product Offered

Table 112. Merck Antibacterial (Drug) Resistance Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 113. Merck Main Business

Table 114. Merck Latest Developments

Table 115. Abbott Laboratories Basic Information, Antibacterial (Drug) Resistance Manufacturing Base, Sales Area and Its Competitors

Table 116. Abbott Laboratories Antibacterial (Drug) Resistance Product Offered

Table 117. Abbott Laboratories Antibacterial (Drug) Resistance Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 118. Abbott Laboratories Main Business

Table 119. Abbott Laboratories Latest Developments

Table 120. Pfizer Basic Information, Antibacterial (Drug) Resistance Manufacturing Base, Sales Area and Its Competitors

Table 121. Pfizer Antibacterial (Drug) Resistance Product Offered

Table 122. Pfizer Antibacterial (Drug) Resistance Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 123. Pfizer Main Business

Table 124. Pfizer Latest Developments

Table 125. GSK Basic Information, Antibacterial (Drug) Resistance Manufacturing Base, Sales Area and Its Competitors

Table 126. GSK Antibacterial (Drug) Resistance Product Offered

Table 127. GSK Antibacterial (Drug) Resistance Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 128. GSK Main Business

Table 129. GSK Latest Developments

Table 130. PENDOPHARM Basic Information, Antibacterial (Drug) Resistance Manufacturing Base, Sales Area and Its Competitors

Table 131. PENDOPHARM Antibacterial (Drug) Resistance Product Offered

Table 132. PENDOPHARM Antibacterial (Drug) Resistance Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 133. PENDOPHARM Main Business

Table 134. PENDOPHARM Latest Developments

Table 135. Absynth Biologics Basic Information, Antibacterial (Drug) Resistance Manufacturing Base, Sales Area and Its Competitors

Table 136. Absynth Biologics Antibacterial (Drug) Resistance Product Offered

Table 137. Absynth Biologics Antibacterial (Drug) Resistance Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 138. Absynth Biologics Main Business

Table 139. Absynth Biologics Latest Developments

Table 140. Achaogen Basic Information, Antibacterial (Drug) Resistance Manufacturing Base, Sales Area and Its Competitors

Table 141. Achaogen Antibacterial (Drug) Resistance Product Offered

Table 142. Achaogen Antibacterial (Drug) Resistance Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 143. Achaogen Main Business

Table 144. Achaogen Latest Developments

Table 145. Acino Holdings Basic Information, Antibacterial (Drug) Resistance Manufacturing Base, Sales Area and Its Competitors

Table 146. Acino Holdings Antibacterial (Drug) Resistance Product Offered

Table 147. Acino Holdings Antibacterial (Drug) Resistance Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 148. Acino Holdings Main Business

Table 149. Acino Holdings Latest Developments

Table 150. Aventis Pharma Basic Information, Antibacterial (Drug) Resistance Manufacturing Base, Sales Area and Its Competitors

Table 151. Aventis Pharma Antibacterial (Drug) Resistance Product Offered

Table 152. Aventis Pharma Antibacterial (Drug) Resistance Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 153. Aventis Pharma Main Business

Table 154. Aventis Pharma Latest Developments

Table 155. Austell Laboratories Basic Information, Antibacterial (Drug) Resistance Manufacturing Base, Sales Area and Its Competitors

Table 156. Austell Laboratories Antibacterial (Drug) Resistance Product Offered

Table 157. Austell Laboratories Antibacterial (Drug) Resistance Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 158. Austell Laboratories Main Business

Table 159. Austell Laboratories Latest Developments

Table 160. Assembly Biosciences Basic Information, Antibacterial (Drug) Resistance Manufacturing Base, Sales Area and Its Competitors

Table 161. Assembly Biosciences Antibacterial (Drug) Resistance Product Offered

Table 162. Assembly Biosciences Antibacterial (Drug) Resistance Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 163. Assembly Biosciences Main Business

Table 164. Assembly Biosciences Latest Developments

Table 165. Arpida Basic Information, Antibacterial (Drug) Resistance Manufacturing Base, Sales Area and Its Competitors

Table 166. Arpida Antibacterial (Drug) Resistance Product Offered

Table 167. Arpida Antibacterial (Drug) Resistance Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 168. Arpida Main Business

Table 169. Arpida Latest Developments

Table 170. Demuris Basic Information, Antibacterial (Drug) Resistance Manufacturing Base, Sales Area and Its Competitors

Table 171. Demuris Antibacterial (Drug) Resistance Product Offered

Table 172. Demuris Antibacterial (Drug) Resistance Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 173. Demuris Main Business

Table 174. Demuris Latest Developments

Table 175. Evolva Holding Basic Information, Antibacterial (Drug) Resistance Manufacturing Base, Sales Area and Its Competitors

Table 176. Evolva Holding Antibacterial (Drug) Resistance Product Offered

Table 177. Evolva Holding Antibacterial (Drug) Resistance Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 178. Evolva Holding Main Business

Table 179. Evolva Holding Latest Developments

Table 180. ContraFect Basic Information, Antibacterial (Drug) Resistance Manufacturing Base, Sales Area and Its Competitors

Table 181. ContraFect Antibacterial (Drug) Resistance Product Offered

Table 182. ContraFect Antibacterial (Drug) Resistance Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 183. ContraFect Main Business

Table 184. ContraFect Latest Developments

Table 185. Cerexa Basic Information, Antibacterial (Drug) Resistance Manufacturing Base, Sales Area and Its Competitors

Table 186. Cerexa Antibacterial (Drug) Resistance Product Offered

Table 187. Cerexa Antibacterial (Drug) Resistance Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 188. Cerexa Main Business

Table 189. Cerexa Latest Developments

Table 190. InterMune Basic Information, Antibacterial (Drug) Resistance Manufacturing Base, Sales Area and Its Competitors

Table 191. InterMune Antibacterial (Drug) Resistance Product Offered

Table 192. InterMune Antibacterial (Drug) Resistance Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 193. InterMune Main Business

Table 194. InterMune Latest Developments

Table 195. Isis Pharmaceuticals Basic Information, Antibacterial (Drug) Resistance Manufacturing Base, Sales Area and Its Competitors

Table 196. Isis Pharmaceuticals Antibacterial (Drug) Resistance Product Offered

Table 197. Isis Pharmaceuticals Antibacterial (Drug) Resistance Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 198. Isis Pharmaceuticals Main Business

Table 199. Isis Pharmaceuticals Latest Developments

Table 200. Lyndra Basic Information, Antibacterial (Drug) Resistance Manufacturing Base, Sales Area and Its Competitors

Table 201. Lyndra Antibacterial (Drug) Resistance Product Offered

Table 202. Lyndra Antibacterial (Drug) Resistance Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 203. Lyndra Main Business

Table 204. Lyndra Latest Developments

Table 205. Microbecide Basic Information, Antibacterial (Drug) Resistance Manufacturing Base, Sales Area and Its Competitors

Table 206. Microbecide Antibacterial (Drug) Resistance Product Offered

Table 207. Microbecide Antibacterial (Drug) Resistance Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 208. Microbecide Main Business

Table 209. Microbecide Latest Developments

Table 210. Morphochem Basic Information, Antibacterial (Drug) Resistance Manufacturing Base, Sales Area and Its Competitors

Table 211. Morphochem Antibacterial (Drug) Resistance Product Offered

Table 212. Morphochem Antibacterial (Drug) Resistance Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 213. Morphochem Main Business

Table 214. Morphochem Latest Developments

Table 215. Nabriva Therapeutics Basic Information, Antibacterial (Drug) Resistance Manufacturing Base, Sales Area and Its Competitors

Table 216. Nabriva Therapeutics Antibacterial (Drug) Resistance Product Offered

Table 217. Nabriva Therapeutics Antibacterial (Drug) Resistance Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 218. Nabriva Therapeutics Main Business

Table 219. Nabriva Therapeutics Latest Developments

Table 220. NanoSafe Coatings Basic Information, Antibacterial (Drug) Resistance Manufacturing Base, Sales Area and Its Competitors

Table 221. NanoSafe Coatings Antibacterial (Drug) Resistance Product Offered

Table 222. NanoSafe Coatings Antibacterial (Drug) Resistance Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 223. NanoSafe Coatings Main Business

Table 224. NanoSafe Coatings Latest Developments

Table 225. Novexel Basic Information, Antibacterial (Drug) Resistance Manufacturing Base, Sales Area and Its Competitors

Table 226. Novexel Antibacterial (Drug) Resistance Product Offered

Table 227. Novexel Antibacterial (Drug) Resistance Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 228. Novexel Main Business

Table 229. Novexel Latest Developments

Table 230. Osel Basic Information, Antibacterial (Drug) Resistance Manufacturing Base, Sales Area and Its Competitors

Table 231. Osel Antibacterial (Drug) Resistance Product Offered

Table 232. Osel Antibacterial (Drug) Resistance Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 233. Osel Main Business

Table 234. Osel Latest Developments

Table 235. VenatoRx Pharmaceuticals Basic Information, Antibacterial (Drug) Resistance Manufacturing Base, Sales Area and Its Competitors

Table 236. VenatoRx Pharmaceuticals Antibacterial (Drug) Resistance Product Offered

Table 237. VenatoRx Pharmaceuticals Antibacterial (Drug) Resistance Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 238. VenatoRx Pharmaceuticals Main Business

Table 239. VenatoRx Pharmaceuticals Latest Developments

Table 240. AAIPharma Services Basic Information, Antibacterial (Drug) Resistance Manufacturing Base, Sales Area and Its Competitors

Table 241. AAIPharma Services Antibacterial (Drug) Resistance Product Offered

Table 242. AAIPharma Services Antibacterial (Drug) Resistance Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 243. AAIPharma Services Main Business

Table 244. AAIPharma Services Latest Developments

Table 245. ANTABIO Basic Information, Antibacterial (Drug) Resistance Manufacturing Base, Sales Area and Its Competitors

Table 246. ANTABIO Antibacterial (Drug) Resistance Product Offered

Table 247. ANTABIO Antibacterial (Drug) Resistance Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 248. ANTABIO Main Business

Table 249. ANTABIO Latest Developments

List of Figures

Figure 1. Picture of Antibacterial (Drug) Resistance

Figure 2. Antibacterial (Drug) Resistance Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Antibacterial (Drug) Resistance Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Antibacterial (Drug) Resistance Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Antibacterial (Drug) Resistance Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Telavancin (Vibativ)

Figure 10. Product Picture of Ceftaroline Fosamil (Teflaro/ Zinforo)

Figure 11. Product Picture of Fidaxomicin (Dificid / Dificlir)

Figure 12. Product Picture of Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio)

Figure 13. Product Picture of Dalbavancin (Dalvance/ Xydalba)

Figure 14. Product Picture of Tedizolid Phosphate (Sivextro)

Figure 15. Product Picture of Oritavancin (Orbactiv/ Nuvocid)

Figure 16. Product Picture of Ceftolozane-Tazobactam (Zerbaxa)

Figure 17. Product Picture of Ceftazidime-Avibactam (Avycaz/ Zavicefta)

Figure 18. Product Picture of PHASE III DRUGS

Figure 19. Global Antibacterial (Drug) Resistance Sales Market Share by Type in 2021

Figure 20. Global Antibacterial (Drug) Resistance Revenue Market Share by Type (2017-2022)

Figure 21. Antibacterial (Drug) Resistance Consumed in Complicated Urinary Tract Infection (CUTI)

Figure 22. Global Antibacterial (Drug) Resistance Market: Complicated Urinary Tract Infection (CUTI) (2017-2022) & (K Units)

Figure 23. Antibacterial (Drug) Resistance Consumed in Complicated Intra-Abdominal Infections (CIAI)

Figure 24. Global Antibacterial (Drug) Resistance Market: Complicated Intra-Abdominal Infections (CIAI) (2017-2022) & (K Units)

Figure 25. Antibacterial (Drug) Resistance Consumed in Blood Stream Infections (BSI)

Figure 26. Global Antibacterial (Drug) Resistance Market: Blood Stream Infections (BSI) (2017-2022) & (K Units)

Figure 27. Antibacterial (Drug) Resistance Consumed in Clostridium Difficile Infections (CDI)

Figure 28. Global Antibacterial (Drug) Resistance Market: Clostridium Difficile Infections (CDI) (2017-2022) & (K Units)

Figure 29. Antibacterial (Drug) Resistance Consumed in Acute Bacterial Skin And Skin Structure Infections (ABSSSI)

Figure 30. Global Antibacterial (Drug) Resistance Market: Acute Bacterial Skin And Skin Structure Infections (ABSSSI) (2017-2022) & (K Units)

Figure 31. Antibacterial (Drug) Resistance Consumed in Hospital Acquired Bacterial Pneumonia/Ventilator (HABP/VABP)

Figure 32. Global Antibacterial (Drug) Resistance Market: Hospital Acquired Bacterial Pneumonia/Ventilator (HABP/VABP) (2017-2022) & (K Units)

Figure 33. Antibacterial (Drug) Resistance Consumed in Community Acquired Bacterial Pneumonia (CABP)

Figure 34. Global Antibacterial (Drug) Resistance Market: Community Acquired Bacterial Pneumonia (CABP) (2017-2022) & (K Units)

Figure 35. Global Antibacterial (Drug) Resistance Sales Market Share by Indication (2017-2022)

Figure 36. Global Antibacterial (Drug) Resistance Revenue Market Share by Indication in 2021

Figure 37. Antibacterial (Drug) Resistance Revenue Market by Company in 2021 ($ Million)

Figure 38. Global Antibacterial (Drug) Resistance Revenue Market Share by Company in 2021

Figure 39. Global Antibacterial (Drug) Resistance Sales Market Share by Geographic Region (2017-2022)

Figure 40. Global Antibacterial (Drug) Resistance Revenue Market Share by Geographic Region in 2021

Figure 41. Global Antibacterial (Drug) Resistance Sales Market Share by Region (2017-2022)

Figure 42. Global Antibacterial (Drug) Resistance Revenue Market Share by Country/Region in 2021

Figure 43. Americas Antibacterial (Drug) Resistance Sales 2017-2022 (K Units)

Figure 44. Americas Antibacterial (Drug) Resistance Revenue 2017-2022 ($ Millions)

Figure 45. APAC Antibacterial (Drug) Resistance Sales 2017-2022 (K Units)

Figure 46. APAC Antibacterial (Drug) Resistance Revenue 2017-2022 ($ Millions)

Figure 47. Europe Antibacterial (Drug) Resistance Sales 2017-2022 (K Units)

Figure 48. Europe Antibacterial (Drug) Resistance Revenue 2017-2022 ($ Millions)

Figure 49. Middle East & Africa Antibacterial (Drug) Resistance Sales 2017-2022 (K Units)

Figure 50. Middle East & Africa Antibacterial (Drug) Resistance Revenue 2017-2022 ($ Millions)

Figure 51. Americas Antibacterial (Drug) Resistance Sales Market Share by Country in 2021

Figure 52. Americas Antibacterial (Drug) Resistance Revenue Market Share by Country in 2021

Figure 53. United States Antibacterial (Drug) Resistance Revenue Growth 2017-2022 ($ Millions)

Figure 54. Canada Antibacterial (Drug) Resistance Revenue Growth 2017-2022 ($ Millions)

Figure 55. Mexico Antibacterial (Drug) Resistance Revenue Growth 2017-2022 ($ Millions)

Figure 56. Brazil Antibacterial (Drug) Resistance Revenue Growth 2017-2022 ($ Millions)

Figure 57. APAC Antibacterial (Drug) Resistance Sales Market Share by Region in 2021

Figure 58. APAC Antibacterial (Drug) Resistance Revenue Market Share by Regions in 2021

Figure 59. China Antibacterial (Drug) Resistance Revenue Growth 2017-2022 ($ Millions)

Figure 60. Japan Antibacterial (Drug) Resistance Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Korea Antibacterial (Drug) Resistance Revenue Growth 2017-2022 ($ Millions)

Figure 62. Southeast Asia Antibacterial (Drug) Resistance Revenue Growth 2017-2022 ($ Millions)

Figure 63. India Antibacterial (Drug) Resistance Revenue Growth 2017-2022 ($ Millions)

Figure 64. Australia Antibacterial (Drug) Resistance Revenue Growth 2017-2022 ($ Millions)

Figure 65. Europe Antibacterial (Drug) Resistance Sales Market Share by Country in 2021

Figure 66. Europe Antibacterial (Drug) Resistance Revenue Market Share by Country in 2021

Figure 67. Germany Antibacterial (Drug) Resistance Revenue Growth 2017-2022 ($ Millions)

Figure 68. France Antibacterial (Drug) Resistance Revenue Growth 2017-2022 ($ Millions)

Figure 69. UK Antibacterial (Drug) Resistance Revenue Growth 2017-2022 ($ Millions)

Figure 70. Italy Antibacterial (Drug) Resistance Revenue Growth 2017-2022 ($ Millions)

Figure 71. Russia Antibacterial (Drug) Resistance Revenue Growth 2017-2022 ($ Millions)

Figure 72. Middle East & Africa Antibacterial (Drug) Resistance Sales Market Share by Country in 2021

Figure 73. Middle East & Africa Antibacterial (Drug) Resistance Revenue Market Share by Country in 2021

Figure 74. Egypt Antibacterial (Drug) Resistance Revenue Growth 2017-2022 ($ Millions)

Figure 75. South Africa Antibacterial (Drug) Resistance Revenue Growth 2017-2022 ($ Millions)

Figure 76. Israel Antibacterial (Drug) Resistance Revenue Growth 2017-2022 ($ Millions)

Figure 77. Turkey Antibacterial (Drug) Resistance Revenue Growth 2017-2022 ($ Millions)

Figure 78. GCC Country Antibacterial (Drug) Resistance Revenue Growth 2017-2022 ($ Millions)

Figure 79. Manufacturing Cost Structure Analysis of Antibacterial (Drug) Resistance in 2021

Figure 80. Manufacturing Process Analysis of Antibacterial (Drug) Resistance

Figure 81. Industry Chain Structure of Antibacterial (Drug) Resistance

Figure 82. Channels of Distribution

Figure 83. Distributors Profiles